株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

スマートインスリンペンの世界市場:市場機会、市場分析、市場シェア、および将来予測

Global Smart Insulin Pens Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023

発行 Occams Business Research & Consulting Pvt. Ltd. 商品コード 526714
出版日 ページ情報 英文 190 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=108.68円で換算しております。
スマートインスリンペンの世界市場:市場機会、市場分析、市場シェア、および将来予測 Global Smart Insulin Pens Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023
出版日: 2017年07月01日 ページ情報: 英文 190 Pages
概要

当レポートでは、スマートインスリンペンの世界市場を取り上げ、市場成長促進要因、阻害要因、市場機会、市場競争状況等を包括的に検証し、現在の市場シナリオ分析と2023年までの市場予測を行っています。

第1章 序論

  • エグゼクティブ・サマリー
  • 市場評価手法

第2章 市場概要

  • スマートインスリンペンの世界市場:進化と変化
  • 市場の定義および範囲
  • 業界構造
  • 法規制の枠組み
  • 全体市場分析
    • 重要な調査結果主要5項目
    • 市場機会上位5項目
    • 主要5社
    • 競合戦略上位3項目
  • 市場見積分析
  • 戦略的分析
    • 投資 vs. 導入モデル
    • 全方位業界分析
    • Porterのファイブフォースモデル
    • 特許分析
    • シーソー分析
    • 消費者分析および主要購入基準
  • 市場競争分析
    • 重要戦略と分析
    • 市場シェアおよびトップ企業分析
  • 戦略的提言および重要な結論事項
    • 地域別投資機会
    • 新たな用途に向けた市場機会
    • 最速の成長を遂げている分野への投資機会

第3章 市場の決定要素

  • 市場成長促進要因
  • 市場成長阻害要因
  • 市場機会
  • 市場の課題

第4章 市場分類

  • スマートインスリンペンの世界市場のネット接続方式別分析
    • 市場の定義および範囲
    • 決定の裏付けとなるデータベースおよび評価手法
    • 市場分野間の比較分析
    • 市場機会マトリクス
    • 市場分類
  • スマートインスリンペンの世界市場の適応症別分析
    • 市場分類
  • スマートインスリンペンの世界市場の流通チャンネル別分析
    • 市場分類

第5章 市場競争状況

  • 主要戦略

第6章 地域別分析

  • 地域市場分類
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第7章 主要企業プロファイル

目次
Product Code: HME-6080717

The smart insulin pens market is expected to grow with a CAGR of around 18% during the forecast period 2016-2023. The rising prevalence of diabetes is one of the major factor which is increasing the growth of global smart insulin pens market. As per international diabetes federation, it is expected that around 642 million people are expected to suffer from diabetes around the world by the end of 2040. Hence, the growing concern for continuous glucose monitoring for diabetic patients is rising the demand smart insulin devices. Factors such as lack of dose flexibility and privacy and security concern are major challenges restricting the growth of smart insulin pens market.

Geographically,. North America held the highest revenue share in 2016 in smart insulin pens market. The growth in North America market is majorly driven by the increasing adoption of smart glucose monitoring devices and rising prevalence of diabetes in the North America. The Asia Pacific smart insulin pen market is expected to grow with an impressive CAGR during the forecasted period 2016-2023. The growth in the region is mainly driven by rising adoption of smart devices for glucose monitoring which helps to maintain the sugar level of patients. Furthermore, presence of diabetic patient pool in Asian countries such as India, China, Japan, etc. is also contributing to growth in Asia Pacific smart insulin pens market.

The key players of insulin pens market who are actively working for the development of new technology are Abbott(U.S.), Companion Medical Inc. (U.S.), Elli Lilly (U.S.), Emperra Gmbh (Germany), Medtronic's (U.S.) and Jiangsu Delfu Medical Device Co. (China) etc. all such players are adopting various strategic initiative such as product development, investment, research and development, expansion, etc. to sustain in the dynamic market.

The smart insulin pen market is segmented on the basis of connectivity, indication, channel and geography. Based on connectivity global smart insulin pens market report segment includes bluetooth connected smart insulin pens and USB connected smart insulin pens. Bluetooth connected smart insulin pens held the highest revenue share in connectivity segment. The Bluetooth connectivity feature permits automatic insulin data sharing to healthcare providers. The sharing of insulin data automatically helps to track and monitor the patients sugar level. Hence, the features of Bluetooth connected smart insulin pens is boosting the growth in the global smart insulin pens market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL SMART INSULIN PENS MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360-DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. PATENT ANALYSIS
    • 2.7.5. SEE-SAW ANALYSIS
    • 2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES & ANALYSIS
    • 2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. RISING PREVALENCE OF DIABETES
    • 3.1.2. RISING DEMAND FOR DIABETES MANAGEMENT
    • 3.1.3. EXPLOSION OF BLUETOOTH CONNECTED INSULIN PEN
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. PRIVACY AND SECURITY CONCERNS
    • 3.2.2. LACK OF DOSE FLEXIBILITY
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. NEEDLE STICK INJURIES
    • 3.3.2. INCREASING ADOPTION OF MEDICAL MANAGEMENT PROCESS
    • 3.3.3. GROWING DEMAND FOR PERSONALIZED OR PATIENT CENTRIC DEVICES
  • 3.4. MARKET CHALLENGES
    • 3.4.1. HIGH COST OF SMART PENS
    • 3.4.2. LOW ACCURACY CONCERNS

4. MARKET SEGMENTATION

  • 4.1. GLOBAL SMART INSULIN PENS MARKET BY CONNECTIVITY
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBAL BLUETOOTH CONNECTED SMART INSULIN PEN MARKET
        • 4.1.5.1.1. APPLICATION
        • 4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.1.5. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL USB CONNECTED SMART INSULIN PEN MARKET
        • 4.1.5.2.1. APPLICATION
        • 4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.2.5. KEY CONCLUSIONS
  • 4.2. GLOBAL SMART INSULIN PENS MARKET BY INDICATION
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBAL TYPE 1 DIABETES MARKET
        • 4.2.5.1.1. APPLICATION
        • 4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. KEY CONCLUSIONS
      • 4.2.5.2. GLOBAL TYPE 2 DIABETES MARKET
        • 4.2.5.2.1. APPLICATION
        • 4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. KEY CONCLUSIONS
  • 4.3. GLOBAL SMART INSULIN PENS MARKET BY CHANNEL
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBAL CLINICS AND AMBULATORY SURGICAL CENTERS MARKET
        • 4.3.5.1.1. APPLICATION
        • 4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. KEY CONCLUSIONS
      • 4.3.5.2. GLOBAL E-COMMERCE MARKET
        • 4.3.5.2.1. APPLICATION
        • 4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. KEY CONCLUSIONS
      • 4.3.5.3. GLOBAL RETAIL PHARMACIES MARKET
        • 4.3.5.3.1. APPLICATION
        • 4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.3.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGERS & ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURES
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS

6. GEOGRAPHICAL ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL SMART INSULIN PENS MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRIAL END-USER ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ABBOTT
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
    • 7.1.6. STRATEGIC ANALYSIS
  • 7.2. COMMON SENSE INC.
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
    • 7.2.6. STRATEGIC ANALYSIS
  • 7.3. COMPANION MEDICAL INC
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
    • 7.3.6. STRATEGIC ANALYSIS
  • 7.4. DEXCOM
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
    • 7.4.6. STRATEGIC ANALYSIS
  • 7.5. DIABNEXT
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
    • 7.5.6. STRATEGIC ANALYSIS
  • 7.6. DIGITAL MEDICS PTD LTD
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
    • 7.6.6. STRATEGIC ANALYSIS
  • 7.7. ELLI LILLY
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
    • 7.7.6. STRATEGIC ANALYSIS
  • 7.8. EMPERRA GMBH
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
    • 7.8.6. STRATEGIC ANALYSIS
  • 7.9. INNOVATION ZED
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
    • 7.9.6. STRATEGIC ANALYSIS
  • 7.10. MEDTRONIC'S
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
    • 7.10.6. STRATEGIC ANALYSIS
  • 7.11. PENDIQ GMBH
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
    • 7.11.6. STRATEGIC ANALYSIS
  • 7.12. SANOFI
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
    • 7.12.6. STRATEGIC ANALYSIS
  • 7.13. SMARTPLUS
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
    • 7.13.6. STRATEGIC ANALYSIS
  • 7.14. TANDEM DIABETES CARE
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
    • 7.14.6. STRATEGIC ANALYSIS
  • 7.15. OTHERS
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS
    • 7.15.6. STRATEGIC ANALYSIS

LIST OF TABLES

  • 1. GLOBAL SMART INSULIN PENS MARKET BY CONNECTIVITY 2014-2023 ($ MILLION)
  • 2. GLOBAL BLUETOOTH CONNECTED SMART INSULIN PEN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL USB CONNECTED SMART INSULIN PEN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. GLOBAL SMART INSULIN PENS MARKET BY INDICATION 2014-2023 ($ MILLION)
  • 5. GLOBAL TYPE 1 DIABETES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 6. GLOBAL TYPE 2 DIABETES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. GLOBAL SMART INSULIN PENS MARKET BY CHANNEL 2014-2023 ($ MILLION)
  • 8. GLOBAL CLINICS AND AMBULATORY SURGICAL CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 9. GLOBAL E-COMMERCE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 10. GLOBAL RETAIL PHARMACIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 11. NORTH AMERICA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 12. EUROPE SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 13. ASIA PACIFIC SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 14. REST OF THE WORLD SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BLUETOOTH CONNECTED SMART INSULIN PEN MARKET 2014-2023 ($ MILLION)
  • 2. GLOBAL USB CONNECTED SMART INSULIN PEN MARKET 2014-2023 ($ MILLION)
  • 3. GLOBAL TYPE 1 DIABETES MARKET 2014-2023 ($ MILLION)
  • 4. GLOBAL TYPE 2 DIABETES MARKET 2014-2023 ($ MILLION)
  • 5. GLOBAL CLINICS AND AMBULATORY SURGICAL CENTERS MARKET 2014-2023 ($ MILLION)
  • 6. GLOBAL E-COMMERCE MARKET 2014-2023 ($ MILLION)
  • 7. GLOBAL RETAIL PHARMACIES MARKET 2014-2023 ($ MILLION)
  • 8. UNITED STATES (U.S.) SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 9. CANADA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 10. UNITED KINGDOM (UK) SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 11. FRANCE SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 12. GERMANY SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 13. SPAIN SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 14. ROE SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 15. INDIA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 16. CHINA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 17. JAPAN SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 18. AUSTRALIA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 19. ROAPAC SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 20. LATIN AMERICA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 21. MENA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)